BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 38294647)

  • 1. Omics-based molecular classifications empowering in precision oncology.
    Zhou Z; Lin T; Chen S; Zhang G; Xu Y; Zou H; Zhou A; Zhang Y; Weng S; Han X; Liu Z
    Cell Oncol (Dordr); 2024 Jan; ():. PubMed ID: 38294647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology.
    Raufaste-Cazavieille V; Santiago R; Droit A
    Front Mol Biosci; 2022; 9():962743. PubMed ID: 36304921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.
    He X; Liu X; Zuo F; Shi H; Jing J
    Semin Cancer Biol; 2023 Jan; 88():187-200. PubMed ID: 36596352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine.
    Turanli B; Karagoz K; Gulfidan G; Sinha R; Mardinoglu A; Arga KY
    Curr Pharm Des; 2018; 24(32):3778-3790. PubMed ID: 30398107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology.
    Gallo Cantafio ME; Grillone K; Caracciolo D; Scionti F; Arbitrio M; Barbieri V; Pensabene L; Guzzi PH; Di Martino MT
    High Throughput; 2018 Oct; 7(4):. PubMed ID: 30373182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
    Ahmed Z
    Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing neuro-oncology of glial tumors from big data and multidisciplinary studies.
    Lin CA; Berger MS
    J Neurooncol; 2020 Jan; 146(1):1-7. PubMed ID: 31853838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
    Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
    Front Immunol; 2021; 12():687975. PubMed ID: 34276676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
    Li J; Li L; You P; Wei Y; Xu B
    Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
    Ahmed Z
    Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omics sciences and precision medicine in glioblastoma.
    Micheletti C; Bonetti G; Madeo G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Manganotti P; Caruso P; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):77-84. PubMed ID: 37994751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging and the completion of the omics paradigm in breast cancer.
    Leithner D; Horvat JV; Ochoa-Albiztegui RE; Thakur S; Wengert G; Morris EA; Helbich TH; Pinker K
    Radiologe; 2018 Nov; 58(Suppl 1):7-13. PubMed ID: 29947931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the classification of cancer cell lines from multiple omic views.
    Yang X; Wen Y; Song X; He S; Bo X
    PeerJ; 2020; 8():e9440. PubMed ID: 32874774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.
    Akhoundova D; Rubin MA
    Cancer Cell; 2022 Sep; 40(9):920-938. PubMed ID: 36055231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Subtyping of Cancer Based on Robust Graph Neural Network and Multi-Omics Data Integration.
    Yin C; Cao Y; Sun P; Zhang H; Li Z; Xu Y; Sun H
    Front Genet; 2022; 13():884028. PubMed ID: 35646077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.